-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Aligos Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q2 2024.
- Aligos Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $300K, a 25% decline year-over-year.
- Aligos Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $1.29M, a 31.7% decline year-over-year.
- Aligos Therapeutics, Inc. annual Depreciation for 2023 was $1.56M, a 32.4% decline from 2022.
- Aligos Therapeutics, Inc. annual Depreciation for 2022 was $2.31M, a 23.6% decline from 2021.
- Aligos Therapeutics, Inc. annual Depreciation for 2021 was $3.02M, a 10.4% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)